Tasso 80mg Tablets

Introduction to Tasso 80mg Tablet

Tasso 80mg, manufactured by Jenphar Bangladesh, contains Osimertinib, a third-generation EGFR tyrosine kinase inhibitor. It is used to treat non-small cell lung cancer (NSCLC) in patients with specific mutations in the epidermal growth factor receptor (EGFR). Tasso Osimertinib 80mg tablet helps block the abnormal proteins that drive cancer cell growth, slowing or stopping the spread of cancer, particularly in advanced or metastatic NSCLC with EGFR mutations.

This medication is typically prescribed as a first-line treatment or for patients whose cancer has become resistant to earlier treatments. Always take Tasso 80mg as directed by your healthcare provider.